Polyethylene glycol-coated zinc oxide nanoparticle: an efficient nanoweapon to fight against herpes simplex virus type 1
- PMID: 30346253
- DOI: 10.2217/nnm-2018-0089
Polyethylene glycol-coated zinc oxide nanoparticle: an efficient nanoweapon to fight against herpes simplex virus type 1
Abstract
Aim: We aimed to determine the possible inhibitory effects of zinc oxide nanoparticles (ZnO-NPs) and polyethylene glycol (PEG)-coated ZnO-NPs (ZnO-PEG-NPs) on herpes simplex virus type 1 (HSV-1).
Materials & methods: PEGylated ZnO-NPs were synthesized by the mechanical method. Antiviral activity was assessed by 50% tissue culture infectious dose (TCID50) and real-time PCR assays. To confirm the antiviral activity of ZnO-NPs on expression of HSV-1 antigens, indirect immunofluorescence assay was also conducted.
Results: 200 μg/ml ZnO-PEG-NPs could result in 2.5 log10 TCID50 reduction in virus titer, with inhibition rate of approximately 92% in copy number of HSV-1 genomic DNA.
Conclusion: ZnO-PEG-NPs could be proposed as a new agent for efficient HSV-1 inhibition. Our results indicated that PEGylation is effective in reducing cytotoxicity and increasing antiviral activity of nanoparticles.
Keywords: HSV-1; PEG; ZnO; antiviral activity; herpes simplex virus; nanoparticle; polyethylene glycol; zinc oxide.
Similar articles
-
Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine.J Biomed Sci. 2019 Sep 10;26(1):70. doi: 10.1186/s12929-019-0563-4. J Biomed Sci. 2019. PMID: 31500628 Free PMC article.
-
Inhibition of herpes simplex virus type 1 by copper oxide nanoparticles.J Virol Methods. 2020 Jan;275:113688. doi: 10.1016/j.jviromet.2019.113688. Epub 2019 Jul 2. J Virol Methods. 2020. PMID: 31271792
-
Investigation of the Inhibition Activity of Aluminium Oxide Nanoparticles for Herpes Simplex Type 1.Arch Razi Inst. 2023 Feb 28;78(1):213-219. doi: 10.22092/ARI.2022.358497.2237. eCollection 2023 Feb. Arch Razi Inst. 2023. PMID: 37312699 Free PMC article.
-
Herpes simplex virus type-1: replication, latency, reactivation and its antiviral targets.Antivir Ther. 2016;21(4):277-86. doi: 10.3851/IMP3018. Epub 2016 Jan 4. Antivir Ther. 2016. PMID: 26726828 Review.
-
Situational antiviral drug prophylaxis for HSV type 1 recurrences.Herpes. 2007 Sep;14(2):37-40. Herpes. 2007. PMID: 17939901 Review.
Cited by
-
Nanotechnology: A Potential Weapon to Fight against COVID-19.Part Part Syst Charact. 2022 Jan;39(1):2100159. doi: 10.1002/ppsc.202100159. Epub 2021 Nov 21. Part Part Syst Charact. 2022. PMID: 35440846 Free PMC article. Review.
-
Zinc and Copper Ions Differentially Regulate Prion-Like Phase Separation Dynamics of Pan-Virus Nucleocapsid Biomolecular Condensates.Viruses. 2020 Oct 18;12(10):1179. doi: 10.3390/v12101179. Viruses. 2020. PMID: 33081049 Free PMC article.
-
Advances in Antiviral Material Development.Chempluschem. 2020 Aug 21;85(9):2105-28. doi: 10.1002/cplu.202000460. Online ahead of print. Chempluschem. 2020. PMID: 32881384 Free PMC article.
-
Antiviral Electrospun Polyamide Three-Layered Mask Filter Containing Metal Oxide Nanoparticles and Black Seed Oil.ACS Omega. 2022 Nov 17;7(48):44438-44447. doi: 10.1021/acsomega.2c06611. eCollection 2022 Dec 6. ACS Omega. 2022. PMID: 36506173 Free PMC article.
-
Masks for COVID-19.Adv Sci (Weinh). 2022 Jan;9(3):e2102189. doi: 10.1002/advs.202102189. Epub 2021 Nov 26. Adv Sci (Weinh). 2022. PMID: 34825783 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical